Cholangiocarcinomas can originate from hepatocytes in mice, Journal of Clinical Investigation, vol.122, issue.8, pp.2911-2915, 2012. ,
DOI : 10.1172/JCI63212DS1
Clinical diagnosis and staging of cholangiocarcinoma, Nature Reviews Gastroenterology & Hepatology, vol.31, issue.9, pp.512-522, 2011. ,
DOI : 10.1038/nrgastro.2011.131
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma, Journal of Hepatology, vol.60, issue.6, pp.1268-1289, 2014. ,
DOI : 10.1016/j.jhep.2014.01.021
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?, Journal of Hepatology, vol.56, issue.4, pp.848-854, 2012. ,
DOI : 10.1016/j.jhep.2011.11.015
Risk factors for cholangiocarcinoma, Hepatology, vol.27, issue.Suppl 2, pp.173-84, 2011. ,
DOI : 10.1002/hep.24351
Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, vol.33, issue.6, pp.1353-1357, 2001. ,
DOI : 10.1053/jhep.2001.25087
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998, Gut, vol.48, issue.6, pp.816-820, 1968. ,
DOI : 10.1136/gut.48.6.816
Descriptive epidemiology of cholangiocarcinoma in Italy, Digestive and Liver Disease, vol.42, issue.7, pp.490-495, 2010. ,
DOI : 10.1016/j.dld.2009.10.009
Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany, Scandinavian Journal of Gastroenterology, vol.45, issue.11, pp.1092-1100, 2011. ,
DOI : 10.1242/dev.029140
Trends in the incidence and management of biliary tract cancer: A French population-based study, Journal of Hepatology, vol.54, issue.2, pp.306-310, 2011. ,
DOI : 10.1016/j.jhep.2010.06.039
Incidence Rates of Intra- and Extrahepatic Cholangiocarcinomas in Denmark From 1978 Through 2002, JNCI Journal of the National Cancer Institute, vol.99, issue.11, pp.895-97, 2007. ,
DOI : 10.1093/jnci/djk201
Molecular Pathogenesis of Cholangiocarcinoma, Digestive Diseases, vol.32, issue.5, pp.564-573, 2014. ,
DOI : 10.1159/000360502
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors, Gastroenterology, vol.142, issue.4, pp.1021-1052, 2012. ,
DOI : 10.1053/j.gastro.2011.12.005
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes, Gastroenterology, vol.144, issue.4, pp.829-869, 2013. ,
DOI : 10.1053/j.gastro.2013.01.001
Frequency of p16INK4A alterations and k-ras mutations in intrahepatic cholangiocarcinoma of the liver, Gut, vol.47, issue.5, pp.721-728, 2000. ,
DOI : 10.1136/gut.47.5.721
KrasG12D and p53 Mutation Cause Primary Intrahepatic Cholangiocarcinoma, Cancer Research, vol.72, issue.6, pp.1557-67, 2012. ,
DOI : 10.1158/0008-5472.CAN-11-3596
K-ras Mutation is Strongly Associated with Perineural Invasion and Represents an Independent Prognostic Factor of Intrahepatic Cholangiocarcinoma after Hepatectomy, Annals of Surgical Oncology, vol.359, issue.S3, pp.675-81 ,
DOI : 10.1245/s10434-012-2224-7
Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line, Hepatology, vol.272, issue.5, pp.1128-1161, 1999. ,
DOI : 10.1002/hep.510300522
Cholangiocarcinoma: risk factors, environmental influences and oncogenesis, Ann Clin Lab Sci, vol.43, issue.2, pp.195-210, 2013. ,
Amplification and overexpression of c-erbB-2,epidermal growth factor receptor, and c-met in biliary tract cancers, The Journal of Pathology, vol.29, issue.3, pp.356-65, 2005. ,
DOI : 10.1002/path.1779
Somatic Mutations of Epidermal Growth Factor Receptor in Bile Duct and Gallbladder Carcinoma, Clinical Cancer Research, vol.12, issue.6, pp.1680-1685, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-1692
Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies, Oncogene, vol.23, issue.41, pp.4861-70, 2013. ,
DOI : 10.1038/onc.2012.617
A Critical Role for Notch Signaling in the Formation of Cholangiocellular Carcinomas, Cancer Cell, vol.23, issue.6, pp.784-95, 2013. ,
DOI : 10.1016/j.ccr.2013.04.019
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis, Gastroenterology, vol.128, issue.5, pp.1354-68, 2005. ,
DOI : 10.1053/j.gastro.2005.01.055
MicroRNAs in Hepatobiliary and Pancreatic Cancers, Frontiers in Genetics, vol.2, pp.2-66, 2011. ,
DOI : 10.3389/fgene.2011.00066
Cholangiocarcinoma, The Lancet, vol.366, issue.9493, pp.1303-1317, 2005. ,
DOI : 10.1016/S0140-6736(05)67530-7
The Epidemiology of Cholangiocarcinoma, Seminars in Liver Disease, vol.24, issue.2, pp.115-140, 2004. ,
DOI : 10.1055/s-2004-828889
Epidemiology of cholangiocarcinoma: An update focusing on risk factors, Cancer Science, vol.49, issue.Suppl 1, pp.579-85, 2010. ,
DOI : 10.1111/j.1349-7006.2009.01458.x
Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study, The American Journal of Gastroenterology, vol.120, issue.7, 2008. ,
DOI : 10.1111/j.1572-0241.2008.01796.x
Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control study, International Journal of Cancer, vol.1, issue.3, pp.638-679, 2007. ,
DOI : 10.1002/ijc.22283
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma, Journal of Hepatology, vol.57, issue.1, pp.69-76, 2012. ,
DOI : 10.1016/j.jhep.2012.02.022
Inflammatory Bowel Disease and Risk of Cholangiocarcinoma: Evidence from a Meta-analysis of Population-based Studies, Asian Pacific Journal of Cancer Prevention, vol.15, issue.8, pp.3477-3482 ,
DOI : 10.7314/APJCP.2014.15.8.3477
The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis, The American Journal of Gastroenterology, vol.4, issue.1, pp.204-207, 2000. ,
DOI : 10.1111/j.1572-0241.2000.01685.x
Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic Cholangiocarcinoma, Annals of Surgical Oncology, vol.15, issue.10, pp.2787-2794 ,
DOI : 10.1245/s10434-008-0081-1
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma, Annals of Surgical Oncology, vol.132, issue.1 Suppl, pp.583-589 ,
DOI : 10.1245/s10434-007-9650-y
Intrahepatic peripheral cholangiocarcinoma: CT evaluation, Abdominal Imaging, vol.25, issue.5, pp.490-496, 2000. ,
DOI : 10.1007/s002610000079
Intrahepatic cholangiocarcinoma: MR appearance., American Journal of Roentgenology, vol.158, issue.1, pp.77-79, 1992. ,
DOI : 10.2214/ajr.158.1.1309221
Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance, Molecular Carcinogenesis, vol.26, issue.4, pp.297-303 ,
DOI : 10.1002/mc.21864
Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma, Journal of Hepatology, vol.49, issue.2, pp.207-223, 2008. ,
DOI : 10.1016/j.jhep.2008.03.025
Management of hepatocellular carcinoma, Hepatology, vol.35, issue.5, pp.1208-1244, 2005. ,
DOI : 10.1002/hep.20933
Surgical Management of Intrahepatic Cholangiocarcinoma - A Population-Based Study, Annals of Surgical Oncology, vol.70, issue.2, pp.600-608, 2008. ,
DOI : 10.1245/s10434-007-9627-x
Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment, Journal of Clinical Oncology, vol.29, issue.23, pp.3140-3145, 2011. ,
DOI : 10.1200/JCO.2011.35.6519
R0 Liver Resections for Primary Malignant Liver Tumors in the Noncirrhotic Liver: A Diagnosis-Related Analysis, Digestive Diseases and Sciences, vol.205, issue.4, pp.887-94, 2009. ,
DOI : 10.1007/s10620-008-0408-6
Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience, Journal of Hepato-Biliary-Pancreatic Sciences, vol.21, issue.3, pp.131-138, 2015. ,
DOI : 10.1002/jhbp.158
Adjuvant Therapy in the Treatment of Biliary Tract Cancer: A Systematic Review and Meta-Analysis, Journal of Clinical Oncology, vol.30, issue.16, pp.1934-1974, 2012. ,
DOI : 10.1200/JCO.2011.40.5381
Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma?: A Phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma, Cancer. 15 oct, vol.95, issue.8, pp.1685-95, 2002. ,
Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients, BMC Cancer, vol.26, issue.4, pp.492-501, 2010. ,
DOI : 10.1200/JCO.2007.14.3529
Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients, Cancer J, vol.12, issue.2, pp.113-135, 2006. ,
Radiation Therapy Is Associated With Improved Survival in the Adjuvant and Definitive Treatment of Intrahepatic Cholangiocarcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.72, issue.5, pp.1495-501, 2008. ,
DOI : 10.1016/j.ijrobp.2008.03.018
Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases, Journal of Cancer Research and Clinical Oncology, vol.135, issue.9, pp.1323-1354, 2010. ,
DOI : 10.1007/s00432-010-0783-1
Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma, Best Practice & Research Clinical Gastroenterology, vol.29, issue.2, pp.319-351, 2015. ,
DOI : 10.1016/j.bpg.2015.02.009
Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: A systematic review and pooled analysis, European Journal of Surgical Oncology (EJSO), vol.41, issue.1, pp.120-127 ,
DOI : 10.1016/j.ejso.2014.09.007
Evidence-Based Approach to Cholangiocarcinoma: A Systematic Review of the Current Literature, Journal of the American College of Surgeons, vol.208, issue.1, pp.134-181, 2009. ,
DOI : 10.1016/j.jamcollsurg.2008.09.007
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer, Annals of Oncology, vol.7, issue.6, pp.593-600, 1996. ,
DOI : 10.1093/oxfordjournals.annonc.a010676
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study ??? The UK ABC-01 Study, British Journal of Cancer, vol.18, issue.4, pp.621-628, 2009. ,
DOI : 10.1002/1097-0142(19841015)54:8<1513::AID-CNCR2820540806>3.0.CO;2-9
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer, New England Journal of Medicine, vol.362, issue.14, pp.1273-81, 2010. ,
DOI : 10.1056/NEJMoa0908721
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan, British Journal of Cancer, vol.69, issue.4, pp.469-74, 2010. ,
DOI : 10.1038/sj.bjc.6605377
Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies, Best Practice & Research Clinical Gastroenterology, vol.29, issue.2, pp.345-53, 2015. ,
DOI : 10.1016/j.bpg.2015.01.002
A phase II study of gemcitabine and oxaliplatin (Oxigem) in unresectable gall bladder cancer, Cancer Chemotherapy and Pharmacology, vol.99, issue.6, pp.497-502, 2010. ,
DOI : 10.1007/s00280-009-1055-0
Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: A large retrospective study, European Journal of Cancer, vol.49, issue.2, pp.329-364, 2013. ,
DOI : 10.1016/j.ejca.2012.08.003
Second-line chemotherapy in advanced biliary cancer: a systematic review, Annals of Oncology, vol.25, issue.12, pp.2328-2366, 2014. ,
DOI : 10.1093/annonc/mdu162
Multidisciplinary Care of Patients with Intrahepatic Cholangiocarcinoma: Updates in Management, Gastroenterology Research and Practice, vol.143, issue.12, pp.1-14, 2015. ,
DOI : 10.1111/ajt.12591
Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma, Liver Transplantation, vol.16, issue.8, pp.934-976, 2011. ,
DOI : 10.1002/lt.22307
Outcomes following resection of intrahepatic cholangiocarcinoma, HPB, vol.17, issue.4, pp.344-351, 2015. ,
DOI : 10.1111/hpb.12359
What prognostic factors are important for resected intrahepatic cholangiocarcinoma?, Journal of Gastroenterology and Hepatology, vol.241, issue.5, pp.766-770, 2008. ,
DOI : 10.1007/s00535-006-1877-z
The Prognosis and Survival Outcome of Intrahepatic Cholangiocarcinoma Following Surgical Resection: Association of Lymph Node Metastasis and Lymph Node Dissection with Survival, Annals of Surgical Oncology, vol.10, issue.11, 2009. ,
DOI : 10.1245/s10434-009-0631-1
Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis, Frontiers of Medicine in China, vol.100, issue.9, pp.457-62, 2010. ,
DOI : 10.1007/s11684-010-0240-1
A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma, JAMA Surgery, vol.149, issue.5, pp.432-438, 2014. ,
DOI : 10.1001/jamasurg.2013.5168
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer, Cancer Treatment Reviews, vol.39, issue.5, pp.534-540, 2013. ,
DOI : 10.1016/j.ctrv.2012.08.003
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study, British Journal of Cancer, vol.3, issue.4, pp.726-734, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.109.851873
Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma, Journal of Hepato-Biliary-Pancreatic Sciences, vol.75, issue.8, pp.389-395, 2013. ,
DOI : 10.1007/s00534-012-0550-6
Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status, Medical Oncology, vol.35, issue.2, p.287, 2014. ,
DOI : 10.1007/s12032-014-0287-y
The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection, Medical Oncology, vol.246, issue.1, p.787, 2014. ,
DOI : 10.1007/s12032-013-0787-1
Evaluation of inflammationbased prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma, J Gastroenterol, 2015. ,
Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer, Anticancer Res, 2015. ,
Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer, Interactive CardioVascular and Thoracic Surgery, vol.21, issue.5, p.206, 2015. ,
DOI : 10.1093/icvts/ivv206
Glasgow Prognostic Score Predicts Clinical Outcomes in Patients with Pancreatic Cancer Undergoing Adjuvant Gemcitabine Monotherapy After Curative Surgery, Anticancer Res, vol.35, issue.9, pp.4865-70, 2015. ,
Preoperative Neutrophil to Lymphocyte Ratio and Prognostic Nutritional Index Predict Overall Survival After Hepatectomy for Hepatocellular Carcinoma, World Journal of Surgery, vol.23, issue.6, pp.1501-1510 ,
DOI : 10.1007/s00268-015-2982-z
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma, HPB, vol.10, issue.2, pp.77-82, 2008. ,
DOI : 10.1080/13651820801992641
Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness, Investigational New Drugs, vol.24, issue.5, pp.1066-1072, 2011. ,
DOI : 10.1007/s10637-010-9417-3